BID Act of 2023

12/15/2023, 3:55 PM

Better Interoperability for Devices Act of 2023 or the BID Act of 2023

This bill requires the Food and Drug Administration to report on the interoperability of medical devices, including associated standards, data, and costs.

Bill 118 HR 1557, also known as the BID Act of 2023, is a piece of legislation introduced in the US Congress. The purpose of this bill is to establish a program to provide funding and support for Business Improvement Districts (BIDs) across the country.

BIDs are special districts in which property owners come together to fund and manage improvements and services in their area, such as maintenance, security, and marketing. The BID Act of 2023 aims to promote economic development and revitalization in communities by providing federal grants to support the establishment and operation of BIDs.

The bill outlines the eligibility criteria for BIDs to receive funding, including requirements for governance, transparency, and accountability. It also establishes a competitive grant program to award funds to BIDs that demonstrate a clear plan for improving their district and benefiting the local economy. Additionally, the BID Act of 2023 includes provisions for technical assistance and training to help BIDs effectively manage their operations and achieve their goals. The bill emphasizes the importance of collaboration between BIDs, local governments, and other stakeholders to ensure the success of these districts. Overall, the BID Act of 2023 seeks to support the growth and sustainability of BIDs as a tool for community development and economic prosperity. It aims to empower local businesses and property owners to work together to enhance the quality of life in their neighborhoods and drive economic growth.
Congress
118

Number
HR - 1557

Introduced on
2023-03-10

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

3/10/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Better Interoperability for Devices Act of 2023 or the BID Act of 2023

This bill requires the Food and Drug Administration to report on the interoperability of medical devices, including associated standards, data, and costs.

Bill 118 HR 1557, also known as the BID Act of 2023, is a piece of legislation introduced in the US Congress. The purpose of this bill is to establish a program to provide funding and support for Business Improvement Districts (BIDs) across the country.

BIDs are special districts in which property owners come together to fund and manage improvements and services in their area, such as maintenance, security, and marketing. The BID Act of 2023 aims to promote economic development and revitalization in communities by providing federal grants to support the establishment and operation of BIDs.

The bill outlines the eligibility criteria for BIDs to receive funding, including requirements for governance, transparency, and accountability. It also establishes a competitive grant program to award funds to BIDs that demonstrate a clear plan for improving their district and benefiting the local economy. Additionally, the BID Act of 2023 includes provisions for technical assistance and training to help BIDs effectively manage their operations and achieve their goals. The bill emphasizes the importance of collaboration between BIDs, local governments, and other stakeholders to ensure the success of these districts. Overall, the BID Act of 2023 seeks to support the growth and sustainability of BIDs as a tool for community development and economic prosperity. It aims to empower local businesses and property owners to work together to enhance the quality of life in their neighborhoods and drive economic growth.
Alternative Names
Official Title as IntroducedTo require the Secretary of Health and Human Services to submit a report on the interoperability of medical devices.

Policy Areas
Environmental Protection

Comments

Recent Activity

Latest Summary9/19/2023

Better Interoperability for Devices Act of 2023 or the BID Act of 2023

This bill requires the Food and Drug Administration to report on the interoperability of medical devices, including associated standards, data, and costs.


Latest Action3/17/2023
Referred to the Subcommittee on Health.